These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 17432523

  • 21. Malaria vaccines: a toy for travelers or a tool for eradication?
    Genton B.
    Expert Rev Vaccines; 2008 Jul; 7(5):597-611. PubMed ID: 18564015
    [Abstract] [Full Text] [Related]

  • 22. DNA based vaccination with a cocktail of plasmids encoding immunodominant Leishmania (Leishmania) major antigens confers full protection in BALB/c mice.
    Ahmed SB, Touihri L, Chtourou Y, Dellagi K, Bahloul C.
    Vaccine; 2009 Jan 01; 27(1):99-106. PubMed ID: 18951941
    [Abstract] [Full Text] [Related]

  • 23. [Current trends in the development of vaccines].
    Zwisler O.
    Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Feb 01; 180(2-3):165-74. PubMed ID: 2859720
    [Abstract] [Full Text] [Related]

  • 24. [The control of great endemies in 1984].
    Marques AC.
    Rev Bras Malariol Doencas Trop; 1985 Feb 01; 37():77-92. PubMed ID: 3939611
    [No Abstract] [Full Text] [Related]

  • 25. Immunological aspects of some parasitic infections.
    Ruitenberg EJ, Buys J.
    Tijdschr Diergeneeskd; 1980 Jul 15; 105(14):suppl 3:166-75. PubMed ID: 6999658
    [Abstract] [Full Text] [Related]

  • 26. Vaccines for parasitic diseases.
    Price VL, Kieny MP.
    Curr Drug Targets Infect Disord; 2001 Nov 15; 1(3):315-24. PubMed ID: 12455404
    [Abstract] [Full Text] [Related]

  • 27. [Parasitic diseases: a challenge to medical science].
    Mauël J.
    Rev Med Suisse Romande; 1982 Jan 15; 102(1):41-5. PubMed ID: 7071440
    [No Abstract] [Full Text] [Related]

  • 28. [Variations in human parasitic diseases: malaria and schistosomiasis (author's transl)].
    Garin JP.
    Bull Soc Pathol Exot Filiales; 1981 Jan 15; 74(6):739-49. PubMed ID: 7343140
    [Abstract] [Full Text] [Related]

  • 29. Methods for determining vaccine efficacy and effectiveness and the main barriers to developing a fully deployable malaria vaccine.
    Guinovart C, Alonso PL.
    Am J Trop Med Hyg; 2007 Dec 15; 77(6 Suppl):276-81. PubMed ID: 18165503
    [Abstract] [Full Text] [Related]

  • 30. Veterinary parasitic vaccines: pitfalls and future directions.
    Vercruysse J, Knox DP, Schetters TP, Willadsen P.
    Trends Parasitol; 2004 Oct 15; 20(10):488-92. PubMed ID: 15363443
    [Abstract] [Full Text] [Related]

  • 31. Efficacy of killed whole-parasite vaccines in the prevention of leishmaniasis: a meta-analysis.
    Noazin S, Khamesipour A, Moulton LH, Tanner M, Nasseri K, Modabber F, Sharifi I, Khalil EA, Bernal ID, Antunes CM, Smith PG.
    Vaccine; 2009 Jul 30; 27(35):4747-53. PubMed ID: 19540273
    [Abstract] [Full Text] [Related]

  • 32. Update on the clinical development of candidate malaria vaccines.
    Ballou WR, Arevalo-Herrera M, Carucci D, Richie TL, Corradin G, Diggs C, Druilhe P, Giersing BK, Saul A, Heppner DG, Kester KE, Lanar DE, Lyon J, Hill AV, Pan W, Cohen JD.
    Am J Trop Med Hyg; 2004 Aug 30; 71(2 Suppl):239-47. PubMed ID: 15331843
    [Abstract] [Full Text] [Related]

  • 33. Anti-parasite vaccines.
    McLaren DJ, Terry RJ.
    Trans R Soc Trop Med Hyg; 1989 Aug 30; 83(2):145-6, 178. PubMed ID: 2692216
    [No Abstract] [Full Text] [Related]

  • 34. DNA vaccines against tropical parasitic diseases.
    Da'dara AA, Harn DA.
    Expert Rev Vaccines; 2005 Aug 30; 4(4):575-89. PubMed ID: 16117713
    [Abstract] [Full Text] [Related]

  • 35. Live attenuated vaccines, a favorable strategy to provide long-term immunity against protozoan diseases.
    Solana JC, Moreno J, Iborra S, Soto M, Requena JM.
    Trends Parasitol; 2022 Apr 30; 38(4):316-334. PubMed ID: 34896016
    [Abstract] [Full Text] [Related]

  • 36. [Dengue fever: from disease to vaccination].
    Teyssou R.
    Med Trop (Mars); 2009 Aug 30; 69(4):333-4. PubMed ID: 19725380
    [Abstract] [Full Text] [Related]

  • 37. New concepts in vaccine development in malaria.
    Kanoi BN, Egwang TG.
    Curr Opin Infect Dis; 2007 Jun 30; 20(3):311-6. PubMed ID: 17471043
    [Abstract] [Full Text] [Related]

  • 38. [Research progress and prospects for vaccines against parasitic diseases].
    Liu SX, Cao JP.
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2005 Oct 30; 23(5 Suppl):362-8, 373. PubMed ID: 16562469
    [No Abstract] [Full Text] [Related]

  • 39. Report of a consultation on the optimization of clinical challenge trials for evaluation of candidate blood stage malaria vaccines, 18-19 March 2009, Bethesda, MD, USA.
    Moorthy VS, Diggs C, Ferro S, Good MF, Herrera S, Hill AV, Imoukhuede EB, Kumar S, Loucq C, Marsh K, Ockenhouse CF, Richie TL, Sauerwein RW.
    Vaccine; 2009 Sep 25; 27(42):5719-25. PubMed ID: 19654061
    [Abstract] [Full Text] [Related]

  • 40. Viral vectors in malaria vaccine development.
    Limbach KJ, Richie TL.
    Parasite Immunol; 2009 Sep 25; 31(9):501-19. PubMed ID: 19691555
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.